VANCOUVER, British Columbia, November 14, 2017 /PRNewswire/ --
MYM Nutraceuticals Inc. (CSE:MYM)(CSE: MYM.CN)(MYM.CN) (OTC:MYMMF)(the "Company" or "MYM") is pleased to announce that PUF Ventures Australia ("PVA") has completed filing of multiple applications with the Office of Drug Control in Australia for MYM's Northern Rivers Project.
Michael Horsfall, CEO of PVA stated, "We expect our application to be successful and are moving ahead with building permits, infrastructure, and other applications to support the growth of the company. We have World Class team in Australia and Canada involved in the company who are all excited to be involved in the largest Medical Cannabis Project in the Southern Hemisphere. We have increased the overall scale of the project by about 20% as we see the demand in Australia and export of Cannabis products growing exponentially."
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. MYM has two production projects in Quebec that when completed will have over 1.5 million sqft of production space. MYM is also a partner in a 1.2 million sqft production project (Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that recently legalized cannabis and MYM is a pioneering leader there. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).
ON BEHALF OF THE BOARD
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on http://www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
Rob Gietl, CEO MYM Nutraceuticals Inc. http://www.mymarijuana.ca Investor Relations Terry Brown 1-855-696-2261 D. 1-778-522-2261 Investor Relations Terry Brown 1-855-696-2261 D. +1-778-522-2261
SOURCE MYM Nutraceuticals Inc.
Subscribe to our Free Newsletters!
Blood groups are of four important groups determined by the presence or absence of specific ...
Spermatocele is a condition in which there is a blockage in the epididymal duct, resulting in semen ...
Be a blood donor and save lives for your donated blood is separated into blood products or just ...View All